Source: PR Newswire

Press Release: Concert Genetics : Concert Genetics Earns Patent for Innovative Methods of Automating Genetic Test Coverage and Payment Accuracy

NASHVILLE, Tenn., June 9, 2021 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued Concert Genetics patent US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today. As the patent...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Rob Metcalf's photo - CEO of Concert Genetics

CEO

Rob Metcalf

CEO Approval Rating

89/100

Read more